Inventor · disambiguated record
Shlomo Melmed
Also filed as: MELMED SHLOMO
21 granted patents·18 pending applications·102 citations·filing 1994–2011
94Inventor score
Files withCEDARS SINAI MEDICAL CENTER23FUKUOKA HIDENORI2BEN-SHLOMO ANAT1MELMED SHLOMO1TONG YUNGUANG1
Top patents by PatentIndex Score
39 records- 0179US6858586B2Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformationCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Feb 22, 2005·3 cites·22 claims
- 0276US6750327B2Compositions and method for determining the presence of human PTTG peptide in a sampleCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Jun 15, 2004·3 cites·8 claims
- 0373US6835380B2Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptidesCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Dec 28, 2004·2 cites·4 claims
- 0470US5824838ATransgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditionsCEDARS SINAI MEDICAL CENTER·Filed 1996·Granted Oct 20, 1998·35 cites·35 claims
- 0568US6673823B2Use of peroxisome proliferator activated receptor (PPAR)-γ ligands as a treatment for pituitary tumors and associated conditions, such as Cushing's syndromeCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Jan 6, 2004·5 cites·15 claims
- 0667US6943018B2Transgenic expression from a SOCS-3 promoter in vertebrate cellsCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Sep 13, 2005·1 cites·5 claims
- 0762US6939544B2Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptidesCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Sep 6, 2005·3 cites·4 claims
- 0861US2003069197A1Pituitary-tumor-transforming-genes, and related productsFiled 2002·Application pending·0 cites
- 0959US6913926B2Method of regulating biological activity of pituitary tumor transforming gene (PTTG)1 using PTTG2CEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Jul 5, 2005·2 cites·16 claims
- 1058US6909030B2PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetesCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Jun 21, 2005·2 cites·18 claims
- 1156US5942412APolynucleic acid encoding variant insulin-like growth factor I receptor beta subunit and receptorCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted Aug 24, 1999·26 cites·55 claims
- 1256US2003186286A1Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humansFiled 2002·Application pending·0 cites
- 1355US2005172346A1Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3CEDARS SINAI MEDICAL CENTER·Filed 2005·Application pending·0 cites
- 1454US6900032B2Human PTTG polypeptide and method for producing itCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted May 31, 2005·0 cites·10 claims
- 1554US6723519B2Compositions and method for determining the presence of rat PTTG peptide in a sampleCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Apr 20, 2004·0 cites·8 claims
- 1654US2005177887A1Somatic cells, germ cells and cell lines derived from a PTTG knockout rodentCEDARS SINAI MEDICAL CENTER·Filed 2005·Application pending·0 cites
- 1753US8709804B2Method for drug screening and characterization by calcium fluxBEN-SHLOMO ANAT·Filed 2005·Granted Apr 29, 2014·2 cites·22 claims
- 1852US2005188429A1Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3CEDARS SINAI MEDICAL CENTER·Filed 2005·Application pending·0 cites
- 1952US2007155770A1Treatment of anoragasmia or delayed orgasmCEDARS SINAI MEDICAL CENTER·Filed 2006·Application pending·0 cites
- 2049US2003140359A1Non-human mammals comprising cells expressing vector-borne rat PTTG carboxy-terminal-related DNAFiled 2002·Application pending·0 cites
- 2149US2003167496A1Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequencesFiled 2002·Application pending·0 cites
- 2249US2003131366A1Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNAFiled 2002·Application pending·0 cites
- 2348US2003186910A1Polynucleotides encoding rat pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformationFiled 2002·Application pending·0 cites
- 2447US9387211B2Methods for treatment of Cushing'S disease and hypercortisolism using gefitinibFUKUOKA HIDENORI·Filed 2011·Granted Jul 12, 2016·0 cites·7 claims
- 2547US2013171073A1Treatment of pituitary corticotroph tumors using r-roscovitineMELMED SHLOMO·Filed 2011·Application pending·0 cites
- 2646US6455305B1Pituitary-tumor-transforming-genes, and related productsCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Sep 24, 2002·2 cites·16 claims
- 2745US7097829B2Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses thereforCEDARS SINAI MEDICAL CENTER·Filed 2002·Granted Aug 29, 2006·0 cites·12 claims
- 2844US8216782B2PTTG1 as a biomarker for cancer treatmentTONG YUNGUANG·Filed 2009·Granted Jul 10, 2012·0 cites·7 claims
- 2944US6541244B1Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humansCEDARS SINAI MEDICAL CENTER·Filed 1999·Granted Apr 1, 2003·6 cites·42 claims
- 3044US2002166136A1Anti-inflammatory therapies using cytokine signaling regulated by a SOCS-3 promoterFiled 2002·Application pending·0 cites
- 3144US2003190641A1Live cell method for observing cellular processesCEDARS SINAI MEDICAL CENTER·Filed 2002·Application pending·0 cites
- 3242US5972893AMethod of treating hyperprolactinemia and prolactinomasCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Oct 26, 1999·10 cites·44 claims
- 3339US2002147162A1Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)Filed 2001·Application pending·0 cites
- 3439US2003018001A1Methods of using pituitary tumor transforming gene (PTTG) carboxy-terminal peptides to inhibit neoplastic cellular proliferation and/or transformation of breast and ovarian cellsFiled 2000·Application pending·0 cites
- 3534US2012308567A1Use of tyrosine kinase inhibitors for treatment of prolactinomaFUKUOKA HIDENORI·Filed 2011·Application pending·0 cites
- 3632US6911320B2Rat PTTG polypeptide and method for producing itCEDARS SINAI MEDICAL CENTER·Filed 2001·Granted Jun 28, 2005·0 cites·10 claims
- 3732US6894031B1Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformationCEDARS SINAI MEDICAL CENTER·Filed 2000·Granted May 17, 2005·0 cites·46 claims
- 3831US2003177511A1Transgenic non-human mammals carrying rat pituitary tumor transforming gene (PTTG) sequencesFiled 2002·Application pending·0 cites
- 3931US2003130219A1Polynucleotides encoding mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shlomo Melmed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →